https://www.thebodypro.com/author/bob-huff

Latest by Bob Huff

Promo Image
Viewpoints

Private Sector Responses: Taking Care of Our Own

Studies of the cost effectiveness of treatment versus prevention found little respect at this conference. The assumptions used in several models presented ranged from inadequate to laughable. One hapless economist was shouted down by a member of ACT ...

Promo Image
Viewpoints

Philosophy in the Boardroom: Pfizer Chairman Takes Barcelona

What does it mean when the least healthy-looking person in a room full of AIDS luminaries is the U.S. Secretary of Health? At a dinner party given by Pfizer Chairman and CEO, Henry (call me "Hank") McKinnell at Antoni Gaudi's most elaborate private r...

Promo Image
Lipodystrophy/Body Fat

Treatment for HIV Wasting Withdrawn

Organon International of West Orange, New Jersey, the only U.S. maker of Deca Durabolin (nandrolone decanoate), an injectable anabolic steroid used by many HIV-positive people to combat AIDS-associated weight loss, has decided to cease marketing the ...

Promo Image

New Targets Bring New Challenges

A new drug to block HIV at a new point in its lifecycle will be a welcome development. But approving a new drug from a new chemical class will also bring great uncertainties. It's not enough to simply be active against HIV, the new drug will also hav...

Promo Image

Patent Primer

Ideas aren't real estate. But when ideas and technical know-how are protected by a legal creation known as a patent, they become a temporary kind of property. Patented ideas are often referred to as intellectual property, a class that also includes c...

Promo Image

Rapid New World

In the U.S., the gold standard for diagnosing HIV infection has evolved into a formal process that respects an individual's need to know the facts about HIV: how the virus is transmitted, how to limit one's risk, and the meaning of a positive test re...

Promo Image

The Genetic Edge: Fighting Drug Resistance in a Protein's Genes

It's well understood that unwavering adherence to one's antiretroviral therapy (ART) regimen gives the best chance of keeping drug levels high enough to sustain suppression of viral replication and allow immune recovery to take root. Yet perfect perf...

Promo Image

High-Cost Diagnostics Offset Low-Cost Drugs

There's still no reason to cheer, but in parts of the developing world drug prices are coming down. Price reductions offered by the major pharmaceutical manufacturers in response to competition from generic drug makers are allowing a few small govern...

Promo Image

Malaria and HIV

Reprinted from amfAR HIV/AIDS Treatment Directory Online, www.amfar.org.

Depending on how you look at it, malaria has either a lot or very little in common with HIV.

Both diseases kill millions of people each year, and both diseases are scourges of...

Promo Image
Viewpoints

What Does R & D Really Cost?

The pharmaceutical industry's trade group, Pharmaceutical Research and Manufacturers of America (PhRMA), has long maintained that developing a single new drug and bringing it to market takes on average 12-15 years and costs $500 million. A new report...